Skip to main content

Table 1 Overview of patient population

From: Impact of beam configuration on VMAT plan quality for Pinnacle3Auto-Planning for head and neck cases

Case Disease type Treatment concept Fractionation Scheme Dose D95 in Gy Fractions Side location
1 SCC, Hypopharynx Primary RCT 59,4/66/69,3 33 bilateral
2 SCC, Oral cavity Adjuvant RT 54/66 30 bilateral
3 SCC, Oropharynx Adjuvant RT 54/66 30 bilateral
4 SCC, Oral cavity Adjuvant RCT 54/66 30 bilateral
5 SCC, Oropharynx Adjuvant RCT 60/66 30 bilateral
6 SCC, Oral cavity Adjuvant RCT 54/66 30 bilateral
7 SCC, Oropharynx Adjuvant RCT 54/66 30 bilateral
8 SCC, Oral cavity Adjuvant RCT 54/66 30 bilateral
9 CUP, Oropharynx Adjuvant RT 52,7/65,1 31 bilateral
10 SCC, Oral cavity Adjuvant RCT 54/66 30 bilateral
11 SCC, Oropharynx Adjuvant RT 54/66 30 unilateral
12 SCC, Oropharynx Adjuvant RCT 54/66 30 unilateral
13 SCC, Oropharynx Adjuvant RCT 60/66 30 unilateral
14 Undifferentiated orbital cancer Adjuvant RT 60/66 30 unilateral
15 SCC, external auditory canal Adjuvant RT 54/66 30 unilateral
16 SCC, occipital skin Adjuvant RT 54/66 30 unilateral
17 SCC, Oropharynx Adjuvant RCT 54/66 30 unilateral
18 SCC, Nasal cavity Adjuvant RT 54/66 30 unilateral
19 SCC, Oral cavity Adjuvant RCT 60/66 30 unilateral
20 NHL of the parotid gland Adjuvant RT 40 20 unilateral
  1. All except one patient (Case #20) were treated with a simultaneously integrated boost technique with 2–3 dose levels
  2. CUP Cancer of Unknown Primacy, RCT Radio-Chemo Therapy, RT Radiotherapy, SCC Squamous Cell Carcinoma
  3. Disease type, treatment concept, fractionation scheme and tumor side location are described for all 20 patients